IBIO vs GILD: Which Stock is Better?

Side-by-side comparison of Ibio Inc and Gilead Sciences Inc in 2026

Comparison Updated:

IBIO

Ibio Inc

$2.06

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricIBIOGILDWinner
Market Cap$72.89M$171.97BGILD
P/E RatioN/A20.44GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth0.1%0.0%IBIO
Gross Margin100.0%78.8%IBIO

Analyze IBIO

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IBIO or GILD a better investment?

Comparing IBIO and GILD: Ibio Inc has a market cap of $72.89M while Gilead Sciences Inc has $171.97B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IBIO and GILD?

IBIO (Ibio Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IBIO or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IBIO or GILD?

IBIO has higher revenue growth at 0.1% vs 0.0% for GILD.

Which company is more profitable: IBIO or GILD?

Ibio Inc (IBIO) has higher gross margins at 100.0% compared to 78.8% for GILD.

Which is the larger company: IBIO or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $171.97B compared to $72.89M for IBIO.

Should I buy IBIO or GILD in 2026?

Both IBIO and GILD have investment merit. IBIO trades at $2.06 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IBIO and GILD stock?

Key differences: Market Cap ($72.89M vs $171.97B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.1% vs 0.0%), Gross Margin (100.0% vs 78.8%).

Popular Stock Comparisons